Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-482-4 | CAS number: 17465-86-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Cyclooctapentylose
- EC Number:
- 241-482-4
- EC Name:
- Cyclooctapentylose
- Cas Number:
- 17465-86-0
- Molecular formula:
- C48H80O40
- IUPAC Name:
- cyclooctapentylose
- Details on test material:
- The test material, coded .gamma.-cyclodextrin, a white powder, was received from the sponsor on October 11, 1989.
The batch number of the sample was V 888 and the CAS. Reg. no. 17465-86-0.
The test substance was stored at room temperature, until use.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Young adult female and male Swiss mice (Charles River CD-1 strain) were obtained from a colony maintained under SPF conditions at Charles River Wiga GmbH, Sulzfeld, F.R. Germany. The animals arrived on November 27, 1990. Upon arrival the animals were checked for overt signs of ill health and anomalies. Following an initial quarantaine and acclimatization period of 6 days, the animals were distributed by computer randomization over 3 groups: a vehicle control group, a test group and a positive control group of 15 males and 15 females each. Each group was fitted with a letter code and a colour code. Within each group the animals were identified individually by earmark and computer reference number. The females were odd numbered and the males even. The remaining mice (6/sex) were kept in reserve. At the start of the study the body weights varied from 25.4 to 33.0 g for males and from 21.4 to 28.4 g for females.
Housing and care
The mice were housed in Makrolon, sterilized cages with a grid cover of stainless steel and with a bedding of sterilized softwood chips. Males were housed individually and females up to five per cage. The room was ventilated with about 10 air changes per hour and maintained at 21.0 - 21.5 °C. Relative humidity was between 62 and 68 percent. Lighting was artificial with a sequence of 12 hours light, 12 hours dark. The mice had free access to the Institute's cereal based, open formula diet for rats and mice, except during a period of 2 to 4 h just prior to treatment, when food was withheld. Tap water was freely available at all times. Diet and tap water are analyzed periodically for nutrients and contaminants.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- saline
- Details on exposure:
- On day 0 the animals of the test group were treated orally by gavage with one single dose of 15 g of the test material in 20 ml demineralised water per kg body weight. The negative control group was treated in an identical way with demineralised water. The positive control group was treated once intraperitoneally with the well-known mutagen mitomycin C in an amount of 1.5 mg in 20 ml saline/kg body weight. The suspension was freshly prepared just prior to use. The animals were weighed on day 0, just prior to gavage. They were inspected at 1 and 4 hours after treatment for signs of ill health or reactions to treatment, and once every day thereafter till the end of the experimental period.
- Duration of treatment / exposure:
- 72h
- Frequency of treatment:
- once
Doses / concentrations
- Remarks:
- Doses / Concentrations:
15 g/20 ml water/kg body weight
Basis:
nominal in water
- No. of animals per sex per dose:
- Test animals: 15 per sex
Control group : 15 per sex
Positive control group: 15 per sex - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- A positive control group (15 males, 15 females) was treated once intraperitoneally with the mutagen mitomycin C in an amount of 1.5 mg per kg body weight.
Examinations
- Tissues and cell types examined:
- Bone marrow cells
- Details of tissue and slide preparation:
- Microscopic examination of the bone marrow smears
The slides to be used for the microscopic examination were randomly coded by a person not involved in the study. Care was taken to ensure that no original slide identifications remained visible. The incidence of MPE (= micronucleated polychromatic erythrocytes) and MNE (= micronucleated normochromatic erythrocytes) and the total numbers of poly- and normochromatic erythrocytes (PE and NE, respectively) were recorded in a total of at least 2000 and maximally 3000 erythrocytes per animal in such a way that a minimum of 1000 PE was observed, if feasible. Slides (one slide per animal) were read by moving from the beginning of the smear (label end) to the leading edge in horizontal lines taking care that areas selected for evaluation were evenly distributed over the whole smear. - Statistics:
- Statistical analysis was carried out in two stages. In the first step of the procedure overall significance tests were carried out as follows: the fraction of MPE, MNE and ME per counted number of PE, NE, and E, respectively, were analysed with a generalized linear model using a binomial error-distribution, and the numbers of PE per 1000 erythrocytes were analyzed with linear regression techniques. Both methods assess the influence of sex (male, female), treatment (vehicle control, test groups), exposure time (24 h, 48 h, 72 h) and the various interactions on the total variation in the data. As a second stage, a posteriori comparisons of treatment groups with the negative control group were carried out with asymptotic t-tests if either the main effect of treatment or the treatment by sex interaction was significant.
For all calculations involved, the Genstat 5 statistical package was used.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The incidences of MPE, MNE and ME per 1000 PE, NE and E, respectively, in control and test animals were mutually fully comparable at each of the three sacrifice times.
The mean number of PE per 1000 E was fully comparable between control and the .gamma.-cyclodextrin treated group, indicating that treatment with .gamma.-cyclodextrin did not result in cytotoxicity for the bone marrow cells. The considerable increase in the incidence of micronucleated erythrocytes (MPE, MNE, ME) and the decrease in the PE counts per 1000 E in positive control animals, demonstrated the sensitivity of the test system.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The results of the present micronucleus test did not provide any evidence of chromosomal damage and/or damage to the mitotic apparatus in bone marrow cells of mice treated orally with a high dose of .gamma.-cyclodextrin.
The reference mutagen, mitomycin C, was clearly positive in this test. - Executive summary:
.gamma.-cyclodextrin was examined for its potential to induce micronuclei in bone marrow of mice in compliance with EEC-protocol B.12, and OECD guideline 474. Test animals (15 males, 15 females) were treated orally with one single dose of 15 g/20 ml water/kg body weight. The control group (15 males, 15, females) was treated in a similar way with the vehicle. A positive control group (15 males, 15 females) was treated once intraperitoneally with the mutagen mitomycin C in an amount of 1.5 mg per kg body weight. At 24, 48 and 72 hours after treatment, 10 controls (5/sex), 10 test animals (5/sex) and 10 positive controls (5/sex) were sacrificed. The incidence of micronucleated poly- and normochromatic erythrocytes (abbreviated MPE and MNE, respectively), and the numbers of poly- and normochromatic erythrocytes (PE and NE) were recorded in a total of at least 2000 and maximally 3000 erythrocytes (E) for each animal, in such a way that a minimum of 1000 PE was observed.
Treatment with the test substance did not induce any apparent signs of intoxication.
The incidence of MPE and MNE in mice treated with .gamma.-cyclodextrin, was fully comparable to that found in the concomitant negative controls.
The number of PE per 1000 E at any of the three sacrifice times after treatment of animals with the test substance was mutually fully comparable.
Animals treated with the mutagen mitomycin C showed an increased incidence of MPE and MNE, and a decrease in the number of PE per 1000 E.
It was concluded that the results of the micronucleus test did not provide any indication of chromosomal damage and/or damage to the mitotic apparatus in bone marrow cells of mice treated orally with a high dose of .gamma.-cyclodextrin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.